In mice, inducing spontaneous necroptosis in subcutaneous murine tumors by overexpressing MLKL mRNA synergized efficiently with anti-PD1 immunotherapy to elicit potent anti-tumor immunity (22). Here, MLKL is linked to neoplasm.